Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bromodomain containing 4 (aa 342-460) (Homo sapiens (Human)) | BDBM438726![]() (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 49-170) (Homo sapiens (Human)) | BDBM362674![]() ((4S)-7-(3,5-dimethylisoxazol-4-yl)-2-[4- (methoxya...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 342-460) (Homo sapiens (Human)) | BDBM438728![]() ((4S)-2-[(3S)-4-acetyl-3-methylpiperazin-1- yl]-7-(...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 342-460) (Homo sapiens (Human)) | BDBM438729![]() ((4S)-7-(3,5-dimethylisoxazol-4-yl)-2-[(3S)- 3-meth...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 342-460) (Homo sapiens (Human)) | BDBM438732![]() (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 49-170) (Homo sapiens (Human)) | BDBM438733![]() (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 49-170) (Homo sapiens (Human)) | BDBM438736![]() (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 49-170) (Homo sapiens (Human)) | BDBM438739![]() (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 342-460) (Homo sapiens (Human)) | BDBM438740![]() (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 342-460) (Homo sapiens (Human)) | BDBM438741![]() (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 342-460) (Homo sapiens (Human)) | BDBM438742![]() (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 49-170) (Homo sapiens (Human)) | BDBM362671![]() ((4S)-7-(3,5-dimethylisoxazol-4-yl)-2-[4- (2,2-dime...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 342-460) (Homo sapiens (Human)) | BDBM362671![]() ((4S)-7-(3,5-dimethylisoxazol-4-yl)-2-[4- (2,2-dime...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 342-460) (Homo sapiens (Human)) | BDBM362428![]() ((4S)-7-(3,5-Dimethylisoxazol-4-yl)-2-(4-isobutyryl...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 49-170) (Homo sapiens (Human)) | BDBM438729![]() ((4S)-7-(3,5-dimethylisoxazol-4-yl)-2-[(3S)- 3-meth...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 342-460) (Homo sapiens (Human)) | BDBM438730![]() ((4S)-7-(3,5-dimethylisoxazol-4-yl)-2-[(3S)- 4-isob...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 49-170) (Homo sapiens (Human)) | BDBM318710![]() (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4- yl)-4-pyridi...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 342-460) (Homo sapiens (Human)) | BDBM438736![]() (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 342-460) (Homo sapiens (Human)) | BDBM438743![]() (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 49-170) (Homo sapiens (Human)) | BDBM362670![]() ((4S)-2-(4-butyrylpiperazin-1-yl)-7-(3,5- dimethyli...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 49-170) (Homo sapiens (Human)) | BDBM362672![]() ((4S)-2-[4-(cyclopropylcarbonyl)piperazin- 1-yl]-7-...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 49-170) (Homo sapiens (Human)) | BDBM438731![]() (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 49-170) (Homo sapiens (Human)) | BDBM438737![]() (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 342-460) (Homo sapiens (Human)) | BDBM438744![]() (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 342-460) (Homo sapiens (Human)) | BDBM362670![]() ((4S)-2-(4-butyrylpiperazin-1-yl)-7-(3,5- dimethyli...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 342-460) (Homo sapiens (Human)) | BDBM362673![]() ((4S)-2-[4-(cyclobutylcarbonyl)piperazin-1- yl]-7-(...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 49-170) (Homo sapiens (Human)) | BDBM438728![]() ((4S)-2-[(3S)-4-acetyl-3-methylpiperazin-1- yl]-7-(...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 49-170) (Homo sapiens (Human)) | BDBM362673![]() ((4S)-2-[4-(cyclobutylcarbonyl)piperazin-1- yl]-7-(...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 342-460) (Homo sapiens (Human)) | BDBM362565![]() ((4S)-2-[(2S)-4-acetyl-2-methylpiperazin-1- yl]-7-(...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 49-170) (Homo sapiens (Human)) | BDBM438734![]() (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 342-460) (Homo sapiens (Human)) | BDBM438739![]() (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 49-170) (Homo sapiens (Human)) | BDBM438740![]() (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 49-170) (Homo sapiens (Human)) | BDBM438743![]() (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 49-170) (Homo sapiens (Human)) | BDBM438745![]() (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 342-460) (Homo sapiens (Human)) | BDBM438745![]() (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 342-460) (Homo sapiens (Human)) | BDBM362674![]() ((4S)-7-(3,5-dimethylisoxazol-4-yl)-2-[4- (methoxya...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 49-170) (Homo sapiens (Human)) | BDBM362504![]() ((4S)-2-[(2R,6S)-4-Acetyl-2,6-dimethylpiperazin-1-y...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 49-170) (Homo sapiens (Human)) | BDBM438730![]() ((4S)-7-(3,5-dimethylisoxazol-4-yl)-2-[(3S)- 4-isob...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 342-460) (Homo sapiens (Human)) | BDBM438734![]() (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 342-460) (Homo sapiens (Human)) | BDBM362504![]() ((4S)-2-[(2R,6S)-4-Acetyl-2,6-dimethylpiperazin-1-y...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 49-170) (Homo sapiens (Human)) | BDBM438727![]() (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 342-460) (Homo sapiens (Human)) | BDBM438727![]() (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 342-460) (Homo sapiens (Human)) | BDBM438733![]() (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 342-460) (Homo sapiens (Human)) | BDBM438737![]() (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 49-170) (Homo sapiens (Human)) | BDBM362428![]() ((4S)-7-(3,5-Dimethylisoxazol-4-yl)-2-(4-isobutyryl...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 342-460) (Homo sapiens (Human)) | BDBM362642![]() ((4S)-2-(5-acetyl-2,5- diazabicyclo[2.2.1]hept-2-yl...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 342-460) (Homo sapiens (Human)) | BDBM318710![]() (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4- yl)-4-pyridi...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 49-170) (Homo sapiens (Human)) | BDBM438738![]() (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 49-170) (Homo sapiens (Human)) | BDBM438742![]() (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 49-170) (Homo sapiens (Human)) | BDBM438744![]() (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 49-170) (Homo sapiens (Human)) | BDBM362642![]() ((4S)-2-(5-acetyl-2,5- diazabicyclo[2.2.1]hept-2-yl...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 342-460) (Homo sapiens (Human)) | BDBM438731![]() (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 49-170) (Homo sapiens (Human)) | BDBM438732![]() (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 342-460) (Homo sapiens (Human)) | BDBM438738![]() (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 49-170) (Homo sapiens (Human)) | BDBM438741![]() (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 342-460) (Homo sapiens (Human)) | BDBM362672![]() ((4S)-2-[4-(cyclopropylcarbonyl)piperazin- 1-yl]-7-...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | <25 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 49-170) (Homo sapiens (Human)) | BDBM438726![]() (N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridi...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | 62.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain containing 4 (aa 49-170) (Homo sapiens (Human)) | BDBM362565![]() ((4S)-2-[(2S)-4-acetyl-2-methylpiperazin-1- yl]-7-(...) | PDB GoogleScholar | UniChem | US Patent | n/a | n/a | 62.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib... | US Patent US10618910 (2020) | |||||||||||
More data for this Ligand-Target Pair |